Phase 1 androgenetic alopecia Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of EPI-001 in Patients With Androgenetic Alopecia
androgenetic alopecia
Epibiotech42 enrolled1 locationNCT07618195
Recruiting
Phase 1Phase 2
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Androgenetic alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd.227 enrolled4 locationsNCT07317544
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Androgenetic alopecia (AGA)
Olix Pharmaceuticals, Inc.158 enrolled1 locationNCT07327359
Recruiting
Phase 1Phase 2
Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
androgenetic alopecia
PT. Prodia Stem Cell Indonesia40 enrolled1 locationNCT07429253
Completed
Phase 1
A single-center study of the safety, tolerability and pharmacokinetics of a single concentration of topical SM04554 (0.25% concentration) solution in male subjects with androgenetic alopecia.
Androgenetic alopecia (AGA)
Samumed Pacific Pty Ltd25 enrolled1 locationACTRN12615000980538